Skip to main content
Berry Genomics Co.,Ltd logo

Berry Genomics Co.,Ltd — Investor Relations & Filings

Ticker · 000710 ISIN · CNE000000PN7 Shenzhen Stock Exchange Professional, scientific and technical activities
Open in API
Filings indexed 2,009 across all filing types
Latest filing 2019-01-08 Regulatory Filings
Country CN China
Listing Shenzhen Stock Exchange 000710

About Berry Genomics Co.,Ltd

https://www.berrygenomics.com

Berry Genomics Co.,Ltd. is a biotechnology enterprise specializing in clinical genomics and genetic testing services. The company focuses on the research, development, and commercialization of genomic technologies for clinical applications. Its core portfolio includes non-invasive prenatal testing (NIPT), utilizing high-throughput sequencing to screen for chromosomal abnormalities. Beyond reproductive health, the company provides genomic solutions for oncology diagnostics, including early cancer screening and companion diagnostics, as well as testing for hereditary diseases. Berry Genomics leverages advanced sequencing platforms and proprietary bioinformatics pipelines to deliver precision medicine tools to healthcare providers and research institutions. The company is recognized for its role in the clinical application of Next-Generation Sequencing (NGS) and its extensive genomic databases used to enhance diagnostic accuracy and therapeutic outcomes.

Recent filings

Filing Released Lang Actions
关于持股5%以上的非控股股东股份被轮候冻结的公告
Regulatory Filings Classification · 95% confidence The document is an announcement regarding the freezing of shares held by a non-controlling shareholder exceeding 5% of the company's shares. It details the shareholder's name, number of shares frozen, dates, and reasons for the freeze. There is no financial data, no mention of financial results, no management discussion, no audit information, or any other report type. The document is a regulatory announcement about shareholding status and legal actions affecting shares. It fits best under Regulatory Filings (RNS) as it is a general regulatory announcement about share freeze and does not fit other more specific categories.
2019-01-08 Chinese
对外投资进展公告
Capital/Financing Update Classification · 95% confidence The document is an announcement regarding the progress of an external investment by the company, including details about the establishment and registration of a new company. It does not contain financial statements, audit information, or detailed financial performance data. It is not a report like an Annual Report or Interim Report, nor is it a regulatory certification or voting result. The content focuses on investment progress and company registration details, which aligns with updates on capital or financing activities. Therefore, the document fits best under Capital/Financing Update (CAP). The document length is short and contains substantive information about the investment, not just a notice or link to a report, so it is not a Report Publication Announcement (RPA).
2019-01-08 Chinese
关于对全资子公司增资事项的进展公告
Capital/Financing Update Classification · 95% confidence The document is a progress announcement regarding the capital increase in a wholly-owned subsidiary of the company. It details the completion of registration procedures for the capital increase and provides specific information about the subsidiary's updated registration and business scope. The document references previous announcements and resolutions but itself is a brief update on the financing activity related to the subsidiary's capital structure. It does not contain financial statements or detailed financial analysis, nor is it a full report or regulatory certification. Therefore, it fits best under the category of Capital/Financing Update (CAP). The document length is short and focused on a financing event, not a report publication or regulatory filing.
2018-12-09 Chinese
关于2018年第三季度报告的更正公告
Regulatory Filings Classification · 95% confidence The document is titled as a correction announcement for the company's 2018 third quarter report, specifically correcting financial data related to entrusted financial management. It references the original 2018 third quarter report and provides corrected figures. The document length is 3446 characters, which is relatively short and primarily serves to amend previously disclosed quarterly financial information rather than presenting a full financial report. According to the MENU VS MEAL rule, since this document is a correction announcement and not the full quarterly report itself, it should not be classified as an Interim/Quarterly Report (IR). Instead, it fits best under Regulatory Filings (RNS) as a correction notice to a previously filed report.
2018-11-28 Chinese
2018年第三季度报告正文（更新后）
Interim / Quarterly Report Classification · 95% confidence The document is titled as the "2018 Third Quarter Report" of the company 成都市贝瑞和康基因技术股份有限公司. It contains detailed financial data such as total assets, net profit, earnings per share, cash flow, and other financial indicators for the third quarter of 2018. It also includes sections on important matters, shareholder information, and financial analysis for the quarter. The length of the document (9791 characters) and the presence of comprehensive financial statements and analysis confirm it is a substantive financial report for a period shorter than a full fiscal year. This matches the definition of an Interim / Quarterly Report (IR). There is no indication that this is merely an announcement or a certification, and it is not a full annual report (10-K). Therefore, the correct classification is IR with high confidence. Q3 2018
2018-11-28 Chinese
2018年第三季度报告全文（更新后）
Interim / Quarterly Report Classification · 100% confidence The document is titled "成都市贝瑞和康基因技术股份有限公司 2018 年第三季度报告全文" which translates to "Chengdu Berry Genomics Co., Ltd. 2018 Third Quarter Report Full Text." It contains detailed financial data including balance sheets, profit and loss statements, cash flow analysis, shareholder information, and management discussion of financial results for the third quarter of 2018. The presence of comprehensive financial statements and analysis for a period shorter than a full fiscal year (quarterly) indicates this is an Interim / Quarterly Report. The document length is substantial (15,000 characters), and it contains actual financial data, not just an announcement or certification. Therefore, it fits the definition of an Interim / Quarterly Report (IR). Q3 2018
2018-11-28 Chinese

Browse filings by year

27 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.